Digital Diagnostics Product Training

LumineticsCore

Digital Diagnostics’s first FDA-cleared product is the AI diagnostic platform Dr. Michael Abramoff had envisioned years earlier. The platform, called LumineticsCore™, detects diabetic retinopathy (including macular edema) in primary care. After completing a rigorous prospective, preregistered clinical trial at primary care sites across the country, LumineticsCore™ became the first FDA-cleared AI diagnostic system to make a diagnosis without physician input.

View Course